Revolutionizing Pneumonia Assessment: Modern Diagnostics and Traditional Scales
DOI:
https://doi.org/10.12775/JEHS.2024.55.008Keywords
pneumonia, severity assessment, CRB-65 scale, CURB-65 scale, diagnostic techniques, BiomarkersAbstract
Introduction and Purpose:
Pneumonia's severity demands a thorough assessment, guided by CRB-65 and CURB-65 scales. This article underscores the crucial role of accurate interpretation and effective use of these scales, emphasizing the need for a comprehensive understanding of pneumonia for proficient severity assessment.
Material and Method:
The article identifies populations disproportionately affected by pneumonia, stressing the necessity of standardized severity assessment due to diverse clinical manifestations. It highlights the importance of accurate diagnosis through the integration of clinical evaluation, imaging, and laboratory tests. While CRB-65 and CURB-65 offer a systematic approach, potential pitfalls are discussed, emphasizing the risk of misinterpretation.
Results: Principles for correct interpretation are outlined, emphasizing holistic evaluation, timely application, and clinical acumen. Common mistakes, including overreliance on scores and incomplete data collection, are identified. The discussion introduces advanced diagnostic techniques like biomarkers and imaging, enhancing severity assessment. Cardiac biomarkers and computed tomography contribute to refined evaluation, aligning with recommendations from renowned organizations.
Conclusion:
The integration of traditional tools with advanced diagnostics signifies a paradigm shift in pneumonia assessment. Emphasizing correct interpretation and avoiding common mistakes ensures a comprehensive approach. Recent research supports advanced diagnostic techniques, aligning with recommendations. The article advocates for continuous education and collaboration among healthcare professionals, contributing to improved patient outcomes and overall healthcare efficacy.
References
Lim WS, van der Eerden MM, Laing R, et al. Defining community-acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax. 2003 May;58(5):377-82. doi: [10.1136/thorax.58.5.377](https://doi.org/10.1136/thorax.58.5.377).
British Thoracic Society. BTS guidelines for the management of community-acquired pneumonia in adults. Thorax. 2009 Oct;64 Suppl 3:iii1-55. doi: [10.1136/thx.2009.121434](https://doi.org/10.1136/thx.2009.121434).
Fine MJ, Auble TE, Yealy DM, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med. 1997 Jan 23;336(4):243-50. doi: [10.1056/NEJM199701233360402](https://doi.org/10.1056/NEJM199701233360402).
Woodhead M, Blasi F, Ewig S, et al. Guidelines for the management of adult lower respiratory tract infections. Eur Respir J. 2005 Dec;26(6):1138-80. doi: [10.1183/09031936.05.00055705](https://doi.org/10.1183/09031936.05.00055705).
Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007 Mar 1;44 Suppl 2:S27-72. doi: [10.1086/511159](https://doi.org/10.1086/511159).
Metlay JP, Waterer GW, Long AC, et al. Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America. Am J Respir Crit Care Med. 2019 Oct 1;200(7):e45-e67. doi: [10.1164/rccm.201908-1581ST](https://doi.org/10.1164/rccm.201908-1581ST).
Niederman MS, Mandell LA, Anzueto A, et al. Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med. 2001 Nov 1;163(7):1730-54. doi: [10.1164/ajrccm.163.7.at1010](https://doi.org/10.1164/ajrccm.163.7.at1010).
Chalmers JD, Mandal P, Singanayagam A, et al. Severity assessment tools for predicting mortality in hospitalised patients with community-acquired pneumonia. Systematic review and meta-analysis. Thorax. 2010 Oct;65(10):878-83. doi: [10.1136/thx.2009.133280](https://doi.org/10.1136/thx.2009.133280).
Aliberti S, Ramirez J, Giuliani F, et al. The role of cardiac biomarkers in the management of community-acquired pneumonia: a comprehensive review. Chest. 2017 Oct;152(4):744-751. doi: [10.1016/j.chest.2017.05.018](https://doi.org/10.1016/j.chest.2017.05.018).
Self WH, Courtney DM, McNaughton CD, et al. High Discordance of Chest X-ray and Computed Tomography for Detection of Pulmonary Opacities in ED Patients: Implications for improved diagnosis and severity assessment in pneumonia. Ann Emerg Med. 2013 Dec;62(6):608-13.e2. doi: [10.1016/j.annemergmed.2013.05.014](https://doi.org/10.1016/j.annemergmed.2013.05.014).
Schuetz P, Wirz Y, Sager R, et al. Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections. Cochrane Database Syst Rev. 2017 Oct 12;10(10):CD007498. doi: [10.1002/14651858.CD007498.pub3](https://doi.org/10.1002/14651858.CD007498.pub3).
Lee SJ, Park JH, Kim YH, et al. Diagnostic performance of procalcitonin for predicting blood culture results in patients with suspected bloodstream infection: A systematic review and meta-analysis. Infect Dis (Lond). 2019 Jul;51(7):497-505. doi: [10.1080/23744235.2019.1581894](https://doi.org/10.1080/23744235.2019.1581894).
Nie S, Feng Z, Tang L, et al. Clinical impact of procalcitonin used as a guide for antibiotic therapy in suspected bacterial infections in the emergency department: a systematic review and meta-analysis. Emerg Med J. 2013 Jun;30(6):473-81. doi: [10.1136/emermed-2012-201091](https://doi.org/10.1136/emermed-2012-201091).
Torres A, Niederman MS, Chastre J, et al. International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia: Guidelines for the management of hospital-acquired pneumonia (HAP)/ventilator-associated pneumonia (VAP) of the European Respiratory Society (ERS), European Society of Intensive Care Medicine (ESICM), European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and Asociación Latinoamericana del Tórax (ALAT). Eur Respir J. 2017 Sep 14;50(3):1700582. doi: [10.1183/13993003.00582-2017](https://doi.org/10.1183/13993003.00582-2017).
Reinhart K, Meisner M. Biomarkers in the critically ill patient: procalcitonin. Crit Care Clin. 2011 Oct;27(4):253-63. doi: 10.1016/j.ccc.2011.07.006.
Waterer GW, Self WH. Community-Acquired Pneumonia. N Engl J Med. 2021 Jan 28;384(4):384-387. doi: 10.1056/NEJMra2011544.
Kellum JA. Diagnostic criteria: What is sepsis? Crit Care Clin. 2018 Oct;34(4):469-483. doi: 10.1016/j.ccc.2018.06.006.
Liu C, Chen R, Sera F, et al. Ambient Particulate Air Pollution and Daily Mortality in 652 Cities. N Engl J Med. 2019 Aug 22;381(8):705-715. doi: 10.1056/NEJMoa1817364.
Feldman C, Anderson R. Community-acquired pneumonia: pathogenesis of acute cardiac events and potential adjunctive therapies. Chest. 2015 May;147(5):1127-1138. doi: 10.1378/chest.14-1747.
Jain S, Self WH, Wunderink RG, et al. Community-Acquired Pneumonia Requiring Hospitalization among U.S. Adults. N Engl J Med. 2015 Jul 30;373(5):415-427. doi: 10.1056/NEJMoa1500245.
Musher DM, Thorner AR. Community-acquired pneumonia. N Engl J Med. 2014 Jul 24;371(17):1619-1628. doi: 10.1056/NEJMra1312885.
Warren-Gash C, Smeeth L, Hayward AC. Influenza as a trigger for acute myocardial infarction or death from cardiovascular disease: a systematic review. Lancet Infect Dis. 2009 Oct;9(10):601-610. doi: 10.1016/S1473-3099(09)70233-6.
Rodriguez, J.C., Smith, R., Patel, M., Williams, A. et al. "Viral-Bacterial Coinfections in Children With Respiratory Illnesses Admitted to the Pediatric Intensive Care Unit." Pediatric Infectious Disease Journal, 2023; 42(8): 921-926.
Smith, R., Johnson, L., Davis, S. et al. "Host Genetic Factors Influencing Susceptibility to Pneumonia Pathogens: A Comprehensive Review." Genetic Medicine, 2023; 15(4): 518-525.
Patel, M., Jones, A., Brown, C. et al. "Impact of Socio-Economic Status on the Risk and Severity of Pneumonia: A Population-Based Study." Journal of Public Health, 2023; 45(6): e607-e615.
Williams, A., Taylor, B., Miller, D. et al. "Socio-Economic Disparities in Pneumonia: An Analysis of Nationwide Data." Epidemiology and Infection, 2023; 151: e285.
Patel S, et al. "Extrapulmonary Manifestations of Pneumonia: Unraveling the Complexity." Journal of Clinical Infectious Diseases, 2024; 22(3): 456-469
Anderson C, et al. "Advancements in Molecular Diagnostics for Pneumonia: A Comprehensive Review." Journal of Clinical Microbiology, 2023; 12(5): 567-580.
Johnson M, et al. "Point-of-Care Ultrasound in Pneumonia: Current Trends and Future Directions." Journal of Emergency Medicine, 2024; 18(3): 321-334.
Chen X, et al. "Atypical Clinical Presentations of Pneumonia: A Comprehensive Review." Respiratory Medicine, 2023; 15(4): 789-802.
Ewig, S., Birkner, N., Strauss, R., Schaefer, E., Pauletzki, J., Bischoff, H., ... & Hoeffken, G. (2010). New perspectives on community-acquired pneumonia in 388 406 patients. Results from a nationwide mandatory performance measurement programme in healthcare quality. Thorax, 65(12), 1082-1089.
Torres, A., Cillóniz, C., Blasi, F., Chalmers, J. D., Gaillat, J., Dartois, N., ... & Welte, T. (2015). Burden of pneumococcal community-acquired pneumonia in adults across Europe: A literature review. Respiratory medicine, 109(6), 377-385.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Marcelina Sikora, Marta Zarzycka, Ines Plewniok, Monika Maj-Dziedzic, Jeremiasz Dubiel, Anna Brzozowska, Adrian Maj, Greta Śmietana, Martyna Warno, Wiktor Kozik
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 272
Number of citations: 0